{"basic_info": {"ticker": "1801", "exchange": "XHKG", "bloomberg_ticker": "1801 HK Equity", "name": "INNOVENT BIOLOGICS INC", "industry": "Biotechnology", "name_chinese_simplified": "信达生物", "period": "2020", "market_value": 112067837952, "total_income": 3843819000, "ccy": "人民币元", "shariah_compliance_summary": "unknown"}, "business_activity_screening": {"summary": [{"shariah_compliance": "compliant", "income": 2367706000, "business_income_over_total_income": 0.6159774952982958}, {"shariah_compliance": "unknown", "income": 1476113000, "business_income_over_total_income": 0.38402250470170424}], "details": [{"business_activity_cn": "医药产品销售收入", "business_activity_en": "Pharmaceutical Products sales", "income": 2367531000, "business_income_over_total_income": 0.6159319676602879, "shariah_compliance": "compliant"}, {"business_activity_cn": "授权费收入", "business_activity_en": "License fee income", "income": 1476113000, "business_income_over_total_income": 0.38402250470170424, "shariah_compliance": "unknown"}, {"business_activity_cn": "研发服务费收入", "business_activity_en": "R & D service fee income", "income": 175000, "business_income_over_total_income": 4.5527638007929094e-05, "shariah_compliance": "compliant"}, {"business_activity_cn": "未分配", "business_activity_en": "Unassigned", "income": 0, "business_income_over_total_income": 0.0, "shariah_compliance": "unknown"}]}, "financial_screening": [{"item": "Debt to Market Capitalization", "amount": 0.011487269536328356, "shariah_compliance": "compliant", "amount_over_market_value": 0.011487269536328356}]}